Havas N.V. (AMS:HAVAS)
17.35
+0.10 (0.58%)
Jun 16, 2026, 11:03 AM CET
Havas Revenue
In the year 2025, Havas had annual revenue of 2.91B EUR with 1.75% growth. Havas had revenue of 1.51B in the half year ending December 31, 2025, a decrease of -3.15%.
Revenue
2.91B
Revenue Growth
+1.75%
P/S Ratio
0.58
Revenue / Employee
135.22K
Employees
21,542
Market Cap
1.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.91B | 50.00M | 1.75% |
| Dec 31, 2024 | 2.86B | -9.00M | -0.31% |
| Dec 31, 2023 | 2.87B | 107.00M | 3.87% |
| Dec 31, 2022 | 2.77B | 424.00M | 18.11% |
| Dec 31, 2021 | 2.34B | 65.00M | 2.86% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Signify | 5.59B |
| Fugro | 1.85B |
| TKH Group | 1.76B |
| AMG Critical Materials | 1.53B |
| Basic-Fit | 1.42B |
| Corbion | 1.27B |
| Lakefront Biotherapeutics NV | 1.04B |
| Flow Traders | 820.82M |
Havas News
- 7 days ago - Havas initiated with a Buy at Berenberg - TheFly
- 2 months ago - Havas Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Havas Slides: Q1 2026 - Filings
- 2 months ago - Havas Earnings release: Q1 2026 - Filings
- 2 months ago - Havas Maintains Its Positive Momentum With a Solid First Quarter, Reporting a Net Revenue Organic Growth of +2.5% - Business Wire
- 4 months ago - Havas Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Havas Annual report: Q4 2025 - Filings
- 4 months ago - Havas Quarterly report: Q4 2025 - Filings